1. Home
  2. IOVA vs ASAN Comparison

IOVA vs ASAN Comparison

Compare IOVA & ASAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.08

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Asana Inc.

ASAN

Asana Inc.

HOLD

Current Price

$7.39

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
ASAN
Founded
2007
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
IOVA
ASAN
Price
$4.08
$7.39
Analyst Decision
Buy
Hold
Analyst Count
10
14
Target Price
$9.00
$12.46
AVG Volume (30 Days)
12.1M
6.4M
Earning Date
05-07-2026
06-02-2026
Dividend Yield
N/A
N/A
EPS Growth
14.84
27.93
EPS
N/A
N/A
Revenue
N/A
$790,806,000.00
Revenue This Year
$47.74
$10.19
Revenue Next Year
$40.31
$7.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.25
52 Week Low
$1.67
$5.38
52 Week High
$5.63
$15.71

Technical Indicators

Market Signals
Indicator
IOVA
ASAN
Relative Strength Index (RSI) 53.47 52.55
Support Level $2.07 $6.83
Resistance Level $4.35 $8.20
Average True Range (ATR) 0.36 0.57
MACD -0.02 -0.04
Stochastic Oscillator 40.45 36.47

Price Performance

Historical Comparison
IOVA
ASAN

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About ASAN Asana Inc.

Asana Inc is the system of action for work, built for the Agentic Enterprise. It provides a comprehensive solution where humans and AI agents can collaborate effectively so that individuals work smarter, teams move faster, and organizations deliver results. Companies use Asana to connect their work to company goals and orchestrate mission-critical workflows like product launches, employee onboarding, resource planning, tracking company-wide strategic initiatives and more. It manages its operations and allocates resources as a single operating and reportable segment. The company generates revenues from subscriptions from paying customers accessing its cloud-based platform.

Share on Social Networks: